 Nathan Avaritt
Concepts (113)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Melanoma | 5 | 2023 | 277 | 0.790 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2023 | 64 | 0.770 |
Why?
| | Sepsis | 2 | 2025 | 240 | 0.370 |
Why?
| | DNA Repair Enzymes | 1 | 2012 | 44 | 0.370 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2012 | 180 | 0.340 |
Why?
| | Neoplasm Proteins | 2 | 2012 | 330 | 0.330 |
Why?
| | DNA-Binding Proteins | 1 | 2012 | 423 | 0.310 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2015 | 868 | 0.300 |
Why?
| | Antineoplastic Agents | 3 | 2023 | 1232 | 0.300 |
Why?
| | Blood Coagulation | 2 | 2025 | 65 | 0.280 |
Why?
| | Bacillus anthracis | 1 | 2025 | 14 | 0.240 |
Why?
| | Anthrax | 1 | 2025 | 9 | 0.240 |
Why?
| | Factor XI | 1 | 2025 | 4 | 0.230 |
Why?
| | Antigens, Bacterial | 1 | 2025 | 55 | 0.230 |
Why?
| | Bacterial Toxins | 1 | 2025 | 52 | 0.230 |
Why?
| | Blood Coagulation Disorders | 1 | 2025 | 41 | 0.230 |
Why?
| | Endothelium, Vascular | 1 | 2025 | 262 | 0.210 |
Why?
| | Mass Spectrometry | 3 | 2015 | 294 | 0.200 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2025 | 238 | 0.200 |
Why?
| | Histones | 3 | 2015 | 318 | 0.200 |
Why?
| | Polyporaceae | 1 | 2023 | 2 | 0.200 |
Why?
| | Electrophoresis, Capillary | 1 | 2023 | 10 | 0.200 |
Why?
| | Amines | 1 | 2023 | 38 | 0.190 |
Why?
| | Cluster Analysis | 1 | 2023 | 237 | 0.190 |
Why?
| | Staphylococcal Infections | 1 | 2025 | 271 | 0.190 |
Why?
| | Staphylococcus aureus | 1 | 2025 | 313 | 0.190 |
Why?
| | Bile Acids and Salts | 1 | 2022 | 81 | 0.180 |
Why?
| | Nevus, Pigmented | 2 | 2012 | 34 | 0.180 |
Why?
| | CTLA-4 Antigen | 1 | 2021 | 32 | 0.180 |
Why?
| | Histone Demethylases | 2 | 2012 | 22 | 0.180 |
Why?
| | Antibodies, Monoclonal | 1 | 2025 | 477 | 0.170 |
Why?
| | Spectrum Analysis, Raman | 1 | 2021 | 42 | 0.170 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2023 | 228 | 0.170 |
Why?
| | Transcription Factor Pit-1 | 1 | 2021 | 17 | 0.170 |
Why?
| | Pituitary Gland, Anterior | 1 | 2021 | 36 | 0.170 |
Why?
| | Cesarean Section | 1 | 2022 | 158 | 0.170 |
Why?
| | Colonic Neoplasms | 1 | 2021 | 162 | 0.160 |
Why?
| | RNA-Binding Proteins | 1 | 2021 | 133 | 0.160 |
Why?
| | Tumor Microenvironment | 1 | 2021 | 274 | 0.150 |
Why?
| | Nerve Tissue Proteins | 1 | 2021 | 193 | 0.150 |
Why?
| | Immunologic Surveillance | 1 | 2017 | 10 | 0.130 |
Why?
| | Tumor Escape | 1 | 2017 | 18 | 0.130 |
Why?
| | Tumor Cells, Cultured | 2 | 2021 | 441 | 0.130 |
Why?
| | Proteomics | 2 | 2025 | 336 | 0.120 |
Why?
| | Papio | 2 | 2025 | 25 | 0.120 |
Why?
| | Animals | 7 | 2025 | 13526 | 0.110 |
Why?
| | Lysine | 1 | 2015 | 91 | 0.110 |
Why?
| | Up-Regulation | 1 | 2015 | 456 | 0.100 |
Why?
| | Acid Anhydride Hydrolases | 1 | 2012 | 14 | 0.090 |
Why?
| | Apoptosis | 3 | 2023 | 1139 | 0.090 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 68 | 0.090 |
Why?
| | DNA, Neoplasm | 1 | 2012 | 146 | 0.090 |
Why?
| | DNA Breaks, Double-Stranded | 1 | 2012 | 76 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 136 | 0.090 |
Why?
| | Mice | 4 | 2023 | 5982 | 0.090 |
Why?
| | DNA Repair | 1 | 2012 | 197 | 0.080 |
Why?
| | Phosphorylation | 1 | 2012 | 533 | 0.080 |
Why?
| | Disease Models, Animal | 2 | 2025 | 1517 | 0.080 |
Why?
| | Immunotherapy | 2 | 2021 | 266 | 0.070 |
Why?
| | Neoplasms | 1 | 2017 | 1334 | 0.060 |
Why?
| | Humans | 9 | 2023 | 53230 | 0.060 |
Why?
| | Skin Neoplasms | 1 | 2011 | 500 | 0.060 |
Why?
| | Cell Line, Tumor | 2 | 2023 | 1470 | 0.060 |
Why?
| | Complement Activation | 1 | 2025 | 27 | 0.060 |
Why?
| | Papio anubis | 1 | 2025 | 5 | 0.060 |
Why?
| | Inflammation Mediators | 1 | 2025 | 115 | 0.050 |
Why?
| | Neutrophils | 1 | 2025 | 153 | 0.050 |
Why?
| | Methylation | 2 | 2015 | 127 | 0.050 |
Why?
| | Tamoxifen | 1 | 2023 | 60 | 0.050 |
Why?
| | Mycelium | 1 | 2023 | 2 | 0.050 |
Why?
| | Trametes | 1 | 2023 | 3 | 0.050 |
Why?
| | Clostridium | 1 | 2022 | 16 | 0.050 |
Why?
| | Cecum | 1 | 2022 | 62 | 0.050 |
Why?
| | Mice, 129 Strain | 1 | 2021 | 37 | 0.040 |
Why?
| | NIH 3T3 Cells | 1 | 2021 | 52 | 0.040 |
Why?
| | Multiple Myeloma | 1 | 2015 | 3082 | 0.040 |
Why?
| | Female | 3 | 2022 | 28782 | 0.040 |
Why?
| | Mice, Inbred BALB C | 1 | 2021 | 310 | 0.040 |
Why?
| | Promoter Regions, Genetic | 1 | 2023 | 465 | 0.040 |
Why?
| | Cell Lineage | 1 | 2021 | 90 | 0.040 |
Why?
| | Somatotrophs | 1 | 2021 | 43 | 0.040 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2021 | 147 | 0.040 |
Why?
| | Amino Acid Sequence | 2 | 2012 | 563 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2022 | 236 | 0.040 |
Why?
| | Molecular Sequence Data | 2 | 2012 | 759 | 0.040 |
Why?
| | Cell Proliferation | 1 | 2023 | 1031 | 0.040 |
Why?
| | Stem Cells | 1 | 2021 | 189 | 0.040 |
Why?
| | Mice, Transgenic | 1 | 2021 | 561 | 0.040 |
Why?
| | Transcription Factors | 1 | 2023 | 571 | 0.040 |
Why?
| | Time Factors | 1 | 2025 | 2991 | 0.040 |
Why?
| | Cells, Cultured | 1 | 2021 | 1569 | 0.030 |
Why?
| | Immunomodulation | 1 | 2017 | 36 | 0.030 |
Why?
| | Middle Aged | 1 | 2012 | 13419 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2017 | 163 | 0.030 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 89 | 0.030 |
Why?
| | Cell Movement | 1 | 2017 | 279 | 0.030 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2015 | 46 | 0.030 |
Why?
| | Cadherins | 1 | 2015 | 62 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2015 | 237 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2017 | 321 | 0.030 |
Why?
| | Pregnancy | 1 | 2022 | 2608 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 2015 | 149 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2015 | 412 | 0.020 |
Why?
| | Male | 1 | 2012 | 27435 | 0.020 |
Why?
| | gp100 Melanoma Antigen | 1 | 2011 | 8 | 0.020 |
Why?
| | Fixatives | 1 | 2011 | 12 | 0.020 |
Why?
| | Tissue Fixation | 1 | 2011 | 35 | 0.020 |
Why?
| | High-Throughput Screening Assays | 1 | 2011 | 39 | 0.020 |
Why?
| | Paraffin Embedding | 1 | 2011 | 52 | 0.020 |
Why?
| | Formaldehyde | 1 | 2011 | 51 | 0.020 |
Why?
| | Peptide Fragments | 1 | 2012 | 209 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2011 | 245 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2011 | 975 | 0.020 |
Why?
|
|
Avaritt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|